CEREBAIN BIOTECH CORP. Business Finance Contracts & Agreements

Form of Securities Purchase Agreement dated March 15, 2019, by and between Cerebain Biotech Corp. and Auctus Fund, LLC (Filed With SEC on April 5, 2019)

Form of Common Stock Purchase Warrant dated March 1, 2019, issued to Auctus Fund LLC (Filed With SEC on April 5, 2019)

Form of Common Stock Purchase Warrant dated March 1, 2019, issued to Crown Bridge Partners, LLC (Filed With SEC on April 5, 2019)

Form of Amendment to the Convertible Promissory Note issued March 26, 2019, to Auctus Fund LLC (Filed With SEC on April 5, 2019)

Form of Amendment to the Convertible Promissory Note issued February 14, 2018, to Crown Bridge Partners, LLC (Filed With SEC on April 5, 2019)

Form of 12% Convertible Promissory Note issued March 15, 2019, to Auctus Fund, LLC (Filed With SEC on April 5, 2019)

Securities Purchase Agreement dated December 10, 2018 (Filed With SEC on December 26, 2018)

Convertible Promissory Note dated December 10, 2018 (Filed With SEC on December 26, 2018)

Amended and Restated Warrant Agreement with EMA Financial dated February 15, 2018 (Filed With SEC on May 15, 2018)

Common Stock Purchase Warrant issued to Crown Bridge Partners, LLC dated February 14, 2018 (Filed With SEC on March 13, 2018)

Common Stock Purchase Warrant issued to EMA Financial, LLC dated February 12, 2018 (Filed With SEC on March 13, 2018)

Convertible Promissory Note issued to EMA Financial, LLC dated February 12, 2018 (Filed With SEC on March 13, 2018)

Securities Purchase Agreement between Cerebain Biotech Corp. and EMA Financial, LLC dated February 12, 2018 (Filed With SEC on March 13, 2018)

Common Stock Purchase Warrant issued to Auctus Fund, LLC dated February 15, 2018 (Filed With SEC on March 13, 2018)

Convertible Promissory Note issued to Auctus Fund, LLC dated February 15, 2018 (Filed With SEC on March 13, 2018)

Securities Purchase Agreement between Cerebain Biotech Corp. and Auctus Fund, LLC dated February 15, 2018 (Filed With SEC on March 13, 2018)

Convertible Promissory Note issued to Crown Bridge Partners, LLC dated February 14, 2018 (Filed With SEC on March 13, 2018)

Securities Purchase Agreement between Cerebain Biotech Corp. and Crown Bridge Partners, LLC dated February 14, 2018 (Filed With SEC on March 13, 2018)

Stock Purchase Agreement with Stockholder dated February 1, 2018 (Filed With SEC on February 6, 2018)

$2,460,000 Amended and Consolidated Promissory Note date January 24, 2017 (Filed With SEC on May 11, 2017)

$2,410,000 Amended and Consolidated Promissory Note dated November 22, 2016 (Filed With SEC on February 10, 2017)

$2,285,000 Amended and Consolidated Promissory Note dated August 1, 2016 (Filed With SEC on November 14, 2016)

DEBT CONVERSION AND STOCK PURCHASE AGREEMENT (Filed With SEC on August 11, 2014)

AMENDED AND CONSOLIDATED CONVERTIBLE PROMISSORY NOTE $1,345,000 May 28, 2014 Dallas, TX (Filed With SEC on August 11, 2014)

AMENDED AND CONSOLIDATED CONVERTIBLE PROMISSORY NOTE $970,000 October 15, 2013 Dallas, TX (Filed With SEC on February 10, 2014)

DEBT CONVERSION AND STOCK PURCHASE AGREEMENT (Filed With SEC on January 6, 2014)

AMENDED AND CONSOLIDATEDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 3, 2013)

AMENDED AND CONSOLIDATED PROMISSORY NOTE $235,000November 1, 2012Irvine, CA (Filed With SEC on February 12, 2013)

PROMISSORY NOTE (Filed With SEC on January 24, 2013)

CONVERTIBLE PROMISSORY NOTE $240,000June 18, 2012 Irvine, CA (Filed With SEC on November 14, 2012)

SHARE EXCHANGE AGREEMENT (Filed With SEC on February 10, 2012)

ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on February 10, 2012)

STOCK PURCHASE AGREEMENT (Filed With SEC on February 10, 2012)